Clinical Trials Browser

Active not recruiting × Neoplasms × obinutuzumab × Clear all

NCT03322865 2025-04-04

Obinutuzumab in Marginal Zone Lymphoma

Phase 2 Active not recruiting

Neoplasms, Lymphoma, B-Cell, Marginal Zone